Since 2000, Gillette has seen approximately 700 patients who have Legg-Calvé-Perthes disease. Legg-Calvé-Perthes disease is one of the most difficult and controversial conditions with which to make treatment-related decisions.
Several orthopedic specialists at Gillette are involved in the International Perthes Study Group (IPSG). The IPSG actively recruits patients for multicenter studies. These studies evaluate potential risk factors for poor outcomes, assess treatment-related outcomes, and will help shape care standards for children who have Legg-Calvé-Perthes for decades to come.
Select Ongoing Studies
- Jennifer Laine, MD: Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
- Georgiadis, A. G., Seeley, M. A., Yellin, J. L., & Sankar, W. N. (2015). The presentation of legg-calve-perthes disease in females. Journal of Children's Orthopaedics, 9(4), 243-247. doi:10.1007/s11832-015-0671-y [doi]